Beximco Pharmaceuticals Limited
BXP.L · LSE
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £6 | £5 | £5 | £5 |
| Dep. & Amort. | £2 | £2 | £0 | £1 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £0 | -£1 | -£2 | -£1 |
| Other Non-Cash | £0 | £0 | £2 | £0 |
| Operating Cash Flow | £8 | £6 | £5 | £6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£2 | -£2 | -£3 | -£3 |
| Net Acquisitions | £0 | £0 | -£5 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£0 | -£0 | £0 | £0 |
| Investing Cash Flow | -£2 | -£3 | -£8 | -£3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£5 | -£2 | £4 | -£1 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | -£2 | -£2 | -£2 | -£1 |
| Other Fin. Act. | £0 | £0 | £0 | -£2 |
| Financing Cash Flow | -£6 | -£4 | £3 | -£3 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | -£0 | -£0 | £0 | £0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1 | £1 | £1 | £1 |
| End Cash | £1 | £1 | £1 | £1 |
| Free Cash Flow | £6 | £3 | £3 | £3 |